DE69026812D1 - Konjugate von "pokeweed" antiviralem protein und monoklonalen antikörpern - Google Patents
Konjugate von "pokeweed" antiviralem protein und monoklonalen antikörpernInfo
- Publication number
- DE69026812D1 DE69026812D1 DE69026812T DE69026812T DE69026812D1 DE 69026812 D1 DE69026812 D1 DE 69026812D1 DE 69026812 T DE69026812 T DE 69026812T DE 69026812 T DE69026812 T DE 69026812T DE 69026812 D1 DE69026812 D1 DE 69026812D1
- Authority
- DE
- Germany
- Prior art keywords
- pokeweed
- conjugates
- antiviral protein
- monoclonal antibodies
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6849—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6819—Plant toxins
- A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Botany (AREA)
- Cell Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38531489A | 1989-07-25 | 1989-07-25 | |
US50352290A | 1990-03-30 | 1990-03-30 | |
PCT/US1990/003921 WO1991001145A1 (en) | 1989-07-25 | 1990-07-12 | Pokeweed antiviral protein - monoclonal antibody conjugates |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69026812D1 true DE69026812D1 (de) | 1996-06-05 |
DE69026812T2 DE69026812T2 (de) | 1996-11-28 |
Family
ID=27010961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69026812T Expired - Fee Related DE69026812T2 (de) | 1989-07-25 | 1990-07-12 | Konjugate von "pokeweed" antiviralem protein und monoklonalen antikörpern |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0441917B1 (de) |
JP (1) | JP3109678B2 (de) |
KR (1) | KR920700698A (de) |
AT (1) | ATE137410T1 (de) |
AU (1) | AU631674B2 (de) |
CA (1) | CA2037900C (de) |
DE (1) | DE69026812T2 (de) |
DK (1) | DK0441917T3 (de) |
ES (1) | ES2087158T3 (de) |
FI (1) | FI911447A0 (de) |
GR (1) | GR1002180B (de) |
IE (1) | IE74143B1 (de) |
IL (1) | IL95134A (de) |
NO (1) | NO911174L (de) |
NZ (1) | NZ234607A (de) |
PT (1) | PT94789B (de) |
WO (1) | WO1991001145A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0425604U (de) * | 1990-06-27 | 1992-02-28 | ||
GB9217124D0 (en) * | 1992-08-13 | 1992-09-23 | Antisoma Ltd | Medical treatment |
US6576236B1 (en) * | 1994-07-01 | 2003-06-10 | Dana Farber Cancer Institute | Methods for stimulating T cell responses by manipulating a common cytokine receptor γ chain |
US5919457A (en) * | 1996-01-11 | 1999-07-06 | Regents Of The University Of Minnesota | TXU-5/B53-PAP antiviral biotherapeutic agent for the treatment of AIDS |
JP6022538B2 (ja) | 2011-04-12 | 2016-11-09 | ノヴォ ノルディスク アー/エス | 二重アシル化されたglp−1誘導体 |
-
1990
- 1990-07-12 DK DK90911551.1T patent/DK0441917T3/da active
- 1990-07-12 AU AU61405/90A patent/AU631674B2/en not_active Ceased
- 1990-07-12 DE DE69026812T patent/DE69026812T2/de not_active Expired - Fee Related
- 1990-07-12 AT AT90911551T patent/ATE137410T1/de not_active IP Right Cessation
- 1990-07-12 CA CA002037900A patent/CA2037900C/en not_active Expired - Fee Related
- 1990-07-12 EP EP90911551A patent/EP0441917B1/de not_active Expired - Lifetime
- 1990-07-12 JP JP02511035A patent/JP3109678B2/ja not_active Expired - Fee Related
- 1990-07-12 ES ES90911551T patent/ES2087158T3/es not_active Expired - Lifetime
- 1990-07-12 KR KR1019910700318A patent/KR920700698A/ko not_active Application Discontinuation
- 1990-07-12 WO PCT/US1990/003921 patent/WO1991001145A1/en active IP Right Grant
- 1990-07-16 IE IE259390A patent/IE74143B1/en not_active IP Right Cessation
- 1990-07-18 GR GR900100550A patent/GR1002180B/el not_active IP Right Cessation
- 1990-07-20 IL IL9513490A patent/IL95134A/en not_active IP Right Cessation
- 1990-07-23 NZ NZ234607A patent/NZ234607A/en unknown
- 1990-07-23 PT PT94789A patent/PT94789B/pt not_active IP Right Cessation
-
1991
- 1991-03-22 NO NO91911174A patent/NO911174L/no unknown
- 1991-03-25 FI FI911447A patent/FI911447A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL95134A (en) | 1996-01-31 |
AU6140590A (en) | 1991-02-22 |
IE74143B1 (en) | 1997-07-02 |
IL95134A0 (en) | 1991-06-10 |
CA2037900C (en) | 1999-11-16 |
NZ234607A (en) | 1992-10-28 |
NO911174D0 (no) | 1991-03-22 |
FI911447A0 (fi) | 1991-03-25 |
CA2037900A1 (en) | 1991-01-26 |
GR1002180B (en) | 1996-03-11 |
KR920700698A (ko) | 1992-08-10 |
JPH04502625A (ja) | 1992-05-14 |
NO911174L (no) | 1991-05-24 |
DK0441917T3 (da) | 1996-09-16 |
IE902593A1 (en) | 1991-02-27 |
EP0441917A1 (de) | 1991-08-21 |
JP3109678B2 (ja) | 2000-11-20 |
PT94789A (pt) | 1991-03-20 |
ATE137410T1 (de) | 1996-05-15 |
AU631674B2 (en) | 1992-12-03 |
GR900100550A (el) | 1991-12-10 |
ES2087158T3 (es) | 1996-07-16 |
WO1991001145A1 (en) | 1991-02-07 |
PT94789B (pt) | 1997-04-30 |
EP0441917B1 (de) | 1996-05-01 |
DE69026812T2 (de) | 1996-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3585087D1 (de) | Retrovirale polypeptide in zusammenhang mit menschlicher transformation. | |
DE69635377D1 (de) | Effiziente anreicherung und detektion von ausgesäten tumorzellen | |
ES2067604T3 (es) | Anticuerpos frente a proteina que se une a tnf i y a sus fragmentos f(ab). | |
DK0523395T3 (da) | Seroreaktive områder på proteinerne E1 og E2 i HPV 16 | |
NO963168L (no) | Immunstimulatoriske monoklonale antistoffer | |
DE3852054D1 (de) | Monoklonale Antikörper gegen Glycolipid-Antigene und ihre Verwendung. | |
DK282987D0 (da) | Lagdelt immunoanalyseorgan til bestemmelse af et antigens tilstedevaerelse, og hvori der anvendes antistoffer beregnet til transport af partikler | |
DK98187D0 (da) | Monoklonale antistoffer og antigen for human ikke-smaacellet lungecarcinoma og visse andre typer human carcinoma | |
DE69026812D1 (de) | Konjugate von "pokeweed" antiviralem protein und monoklonalen antikörpern | |
FR2637897B1 (fr) | Dosages immunologiques de l'azt, derives et conjugues et anticorps | |
ATE193534T1 (de) | Benzodiazepin-derivate sowie deren konjugate mit proteinen und polypeptiden | |
DE69231495D1 (de) | Neue cocain-derivate und protein- und polypeptid-cocain-derivate, konjugate und markierte verbindungen | |
AU8944291A (en) | Immunoassay for the determination of anti-hiv antibodies in human samples | |
DE3585049D1 (de) | Monoklonale antikoerper. | |
TR199800575T1 (en) | Kemokin �-8'in k�sa formlar�. | |
DK0442372T3 (da) | Forbedrede mærkede haptener, fremgangsmåde til deres fremstilling samt anvendelse af disse mærkede haptener ved immunoassays | |
ATE2048T1 (de) | Isolierung von hepatitis be-antigen. | |
DK314886A (da) | Histamin-derivat og -immunogen-konjugat, cellelinie og antistof produceret deraf samt immunbestemmelse af histamin ved hjaelp af antistoffet | |
AU6257486A (en) | Specific mycoplasma membrane antigen and antibody and their clinical applications | |
KR100310413B1 (ko) | 인간의자연형lgM항체 | |
GR890100219A (el) | Ανθρωπινα μονοκλωνικα αντισωματα που ειδικα αναγνωριζουν κυτταραιου λυσσας κυτταρα που παραγουν τα ιδια, διαμορφωσεις που περιε χουν τα ιδια και παραγωγη ολων αυτων. | |
ATE136469T1 (de) | Neue verwendung eines monoklonalen antikörpers | |
NO922878L (no) | Noeytralisering og/eller adcc-formidlende monoklonalt hiv-antistoff | |
DK34393D0 (da) | Humant foetalt antigen 1 (fa1), anvendelse af fa1 og anti-fa1 specifikke antistoffer som biologiske principper og immunoreagenser samt kvantitive teknikker baseret herpaa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |